Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Subcortical brain atrophy persists even in HAART-regulated HIV disease.

Becker JT, Sanders J, Madsen SK, Ragin A, Kingsley L, Maruca V, Cohen B, Goodkin K, Martin E, Miller EN, Sacktor N, Alger JR, Barker PB, Saharan P, Carmichael OT, Thompson PM; Multicenter AIDS Cohort Study.

Brain Imaging Behav. 2011 Jun;5(2):77-85. doi: 10.1007/s11682-011-9113-8.

2.

Structural gray and white matter changes in patients with HIV.

K├╝per M, Rabe K, Esser S, Gizewski ER, Husstedt IW, Maschke M, Obermann M.

J Neurol. 2011 Jun;258(6):1066-75. doi: 10.1007/s00415-010-5883-y. Epub 2011 Jan 5.

PMID:
21207051
3.

Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.

Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B.

J Neurovirol. 2010 Feb;16(1):25-32. doi: 10.3109/13550280903552420.

4.

Multivariate tensor-based morphometry on surfaces: application to mapping ventricular abnormalities in HIV/AIDS.

Wang Y, Zhang J, Gutman B, Chan TF, Becker JT, Aizenstein HJ, Lopez OL, Tamburo RJ, Toga AW, Thompson PM.

Neuroimage. 2010 Feb 1;49(3):2141-57. doi: 10.1016/j.neuroimage.2009.10.086. Epub 2009 Nov 6.

5.

Age, Alzheimer disease, and brain structure.

Raji CA, Lopez OL, Kuller LH, Carmichael OT, Becker JT.

Neurology. 2009 Dec 1;73(22):1899-905. doi: 10.1212/WNL.0b013e3181c3f293. Epub 2009 Oct 21.

6.

Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men.

Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller EN, Ragin A, Sacktor N, Selnes OA, Visscher BR; Multicenter AIDS Cohort Study.

Neurology. 2009 Oct 20;73(16):1292-9. doi: 10.1212/WNL.0b013e3181bd10e7.

7.

White matter microstructural integrity and cognitive function in a general elderly population.

Vernooij MW, Ikram MA, Vrooman HA, Wielopolski PA, Krestin GP, Hofman A, Niessen WJ, Van der Lugt A, Breteler MM.

Arch Gen Psychiatry. 2009 May;66(5):545-53. doi: 10.1001/archgenpsychiatry.2009.5.

PMID:
19414714
8.

Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals.

Cole MA, Margolick JB, Cox C, Li X, Selnes OA, Martin EM, Becker JT, Aronow HA, Cohen B, Sacktor N, Miller EN; Multicenter AIDS Cohort Study.

Neurology. 2007 Dec 11;69(24):2213-20. Epub 2007 Oct 3.

PMID:
17914066
9.

Updated research nosology for HIV-associated neurocognitive disorders.

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE.

Neurology. 2007 Oct 30;69(18):1789-99. Epub 2007 Oct 3.

10.

3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry.

Chiang MC, Dutton RA, Hayashi KM, Lopez OL, Aizenstein HJ, Toga AW, Becker JT, Thompson PM.

Neuroimage. 2007 Jan 1;34(1):44-60. Epub 2006 Oct 10.

11.

3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS.

Thompson PM, Dutton RA, Hayashi KM, Lu A, Lee SE, Lee JY, Lopez OL, Aizenstein HJ, Toga AW, Becker JT.

Neuroimage. 2006 May 15;31(1):12-23. Epub 2006 Jan 19.

PMID:
16427319
12.

CSF amyloid beta42 and tau levels correlate with AIDS dementia complex.

Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L.

Neurology. 2005 Nov 8;65(9):1490-2.

PMID:
16275845
13.

Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline.

Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, Becker JT.

Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15647-52. Epub 2005 Oct 14.

15.

Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients.

Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL.

AIDS. 2005 Mar 4;19(4):407-11.

PMID:
15750394
16.

Diabetes, insulin resistance, and dementia among HIV-1-infected patients.

Valcour VG, Shikuma CM, Shiramizu BT, Williams AE, Watters MR, Poff PW, Grove JS, Selnes OA, Sacktor NC.

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):31-6.

17.

Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort.

Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes OA, Grove J, Liu Y, Abdul-Majid KB, Gartner S, Sacktor N.

J Neuroimmunol. 2004 Dec;157(1-2):197-202.

PMID:
15579298
18.

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

Cysique LA, Maruff P, Brew BJ.

Arch Neurol. 2004 Nov;61(11):1699-704.

PMID:
15534181
19.

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort.

Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor N.

Neurology. 2004 Sep 14;63(5):822-7.

20.

White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke.

Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr; Cardiovascular Health Study Collaborative Research Group.

Stroke. 2004 Aug;35(8):1821-5. Epub 2004 Jun 3.

Supplemental Content

Support Center